Search Results 91-100 of 17368 for GLP-1 secretion

  1. Nateglinide (oral route) - Side effects & dosage - Mayo Clinic

    Nateglinide is used together with diet and exercise to control blood sugar levels in patients with type 2 diabetes. It works by causing your pancreas to release ...

  2. Teriparatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... You may report side effects to ...

  3. Glycopyrrolate (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Aclidinium; Amantadine ...

  4. Muscular dystrophy - Diagnosis & treatment - Mayo Clinic

    Damaged muscles release proteins called enzymes into the blood. These ... Learning that you or a loved one has muscular dystrophy can be very challenging.

  5. Sulfa allergy: Which medicines should I avoid? - Mayo Clinic

    Sulfonamide antibiotics that can cause a reaction · Sulfamethoxazole-trimethoprim (Bactrim, Septra) is taken as a pill. · Silver sulfadiazine (Silvadine, SSD, ...

  6. Glucagon (injection route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Aclidinium; Amantadine ...

  7. Alogliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    ... release more insulin. It also signals the liver ... This medicine does not help patients who have insulin-dependent or type 1 diabetes. ... one or both of the ...

  8. Linagliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    ... release more insulin. It also signals the liver ... This medicine does not help patients who have insulin-dependent or type 1 diabetes. ... one or both of the ...

  9. Publications - Brian E. Lacy, M.D., Ph.D. - Mayo Clinic

    Gastrointestinal Safety Assessment of GLP-1 ... A novel duodenal-release formulation of caraway ... A Novel, Duodenal-Release Formulation of a ...

  10. Multiple endocrine neoplasia, type 2 (MEN 2) - Symptoms and causes - Mayo Clinic

    This condition causes noncancerous tumors on an adrenal gland. The adrenal glands are located at the top of the kidneys. These tumors can release hormones that ...